心筋症(Cardiomyopathy):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2016213)
◆英語タイトル:Cardiomyopathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2016213
◆発行日:2019年06月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,000 ⇒換算¥218,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥654,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[心筋症(Cardiomyopathy):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)]についてメールでお問い合わせはこちら
※当調査レポートでは、心筋症(Cardiomyopathy)治療薬の世界市場動向について調査・分析し、以下の構成でお届けいたします。

・心筋症(Cardiomyopathy):適応症(疾患)の概要
・市販医薬品の状況
・世界のAPI(医薬品原薬)メーカー分析
・地域別APIメーカー状況(アメリカ、ヨーロッパ、中国など)
・心筋症(Cardiomyopathy)のフェーズ3治験薬の状況
・心筋症(Cardiomyopathy)治療薬の市場規模(販売予測)
・心筋症(Cardiomyopathy)の市販医薬品分析
 (医薬品名、説明、APIメーカー、承認状況、特許など)
・心筋症(Cardiomyopathy)のフェーズ3治験薬分析
・開発中止中の心筋症(Cardiomyopathy)治療薬剤
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s Report, “Cardiomyopathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Cardiomyopathy Report is to understand the market and pipeline status of the drugs around the Cardiomyopathy to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2020. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Cardiomyopathy. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market and Phase III therapeutics scenario for Cardiomyopathy.
• A review of the marketed products under prescription for Cardiomyopathy, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Cardiomyopathy with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Cardiomyopathy drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Cardiomyopathy drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Cardiomyopathy drugs.
• Coverage of Cardiomyopathy Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure to 2020.


*** レポート目次(コンテンツ)***

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2020
6. Marketed Drugs for Cardiomyopathy
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Cardiomyopathy
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Cardiomyopathy
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables
• Cardiomyopathy Therapeutic Market, US, Marketed Drugs by Application Type, 2018
• Cardiomyopathy Therapeutic Market, US, Marketed Drugs by Marketing Status, 2018
• Cardiomyopathy Therapeutic Market, US, (Year), 2018
• Cardiomyopathy Marketed Drugs, API Manufacturers by US DMF Status, 2018
• Cardiomyopathy Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Cardiomyopathy Drugs, API Manufacturers, Europe by Country, 2018
• Cardiomyopathy Drugs, API Manufacturers, India by State, 2018
• Cardiomyopathy Drugs, API Manufacturers, China by Province, 2018
• Cardiomyopathy Drugs, API Manufacturers by Geography 2018
• Cardiomyopathy Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Cardiomyopathy Therapeutic Market, Global Sales-2020 (in million USD)
• API Manufacturers for Drug, 2018
• Phase III Drugs for Cardiomyopathy, 2018
• Discontinued Drugs for Cardiomyopathy, 2018


List of Figures
• Cardiomyopathy Therapeutic Market, US, Marketed Drugs by Application Type (%), 2018
• Cardiomyopathy Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2018
• Cardiomyopathy Therapeutic Market, US, (Year), 2018
• Cardiomyopathy Marketed Drugs, API Manufacturers by US DMF Status (%), 2018
• Cardiomyopathy Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Cardiomyopathy Drugs, API Manufacturers, Europe by Country, 2018
• Cardiomyopathy Drugs, API Manufacturers, India by State, 2018
• Cardiomyopathy Drugs, API Manufacturers, China by Province, 2018
• Cardiomyopathy Drugs, API Manufacturers by Geography 2018
• Cardiomyopathy Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Cardiomyopathy Therapeutic Market, Global Sales 2020 (in million USD)
• Drug, Patent/Exclusivity Expiry (Year), 2018


*** レポートのキーワード ***

心筋症(Cardiomyopathy)、薬剤、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品(市販薬)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界のヨウ素酸ナトリウム市場2016
    Notes:Production, means the output of Sodium Iodate Revenue, means the sales value of Sodium Iodate This report studies Sodium Iodate in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, productio …
  • CRISPRのアジア市場
    KEY FINDINGSAsia Pacific is a dominating region for CRISPR market with its applications like agriculture and animal breeding. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is fragments of prokaryotic DNA containing short redundancies of base sequences. The Asia pacific crispr ma …
  • 自動車用熱交換器のアジア市場
    Asia Pacific holds the largest share in automotive heat exchanger market and is projected to dominate during the forecast period as well. Acceleration in the demands for automobiles and manufacturing of the automobile manufacturing sectors in the mentioned regions are driving the market growth. The …
  • 世界の組み込み冷蔵庫市場2015
    The Global Embedded Refrigerator Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Embedded Refrigerator industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structur …
  • 超疎水性コーティングの世界市場2017-2021:フルオロポリマーベース、シリカ系、金属酸化物系、カーボンナノ物質系、その他
    About Superhydrophobic CoatingsSuperhydrophobic coatings are advanced coatings that have the potential to replace the currently used conventional hydrophobic coatings. Superhydrophobicity, also known as the lotus leaf effect, is witnessed in nature in various forms: Leaves, wings of insects, and fea …
  • チオ尿素 S,S-ジオキシドの世界市場2019
    Thiourea S,S-dioxide (CAS 1758-73-2) Market Research Report 2019 aims at providing comprehensive data on Thiourea S,S-dioxide market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Thiourea S,S-dioxide description, covers its application areas, manufactu …
  • 製錬銅の世界及び中国市場 2018年
    The 'Global and Chinese Refined Copper Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Refined Copper industry with a focus on the Chinese market. The report provides key statistics on the market status of the Refined Copper manufac …
  • 血液動態監視装置の世界市場2021
    This report studies Hemodynamic Monitoring Equipment in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering Edwards Lifesciences Corp. IC …
  • エストニアの自己推進式道路建設および土工機械市場(~2020):市場規模、動向、予測
    The report Self-Propelled Road Making and Earth Moving Equipment Market in Estonia to 2020 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for self-propelled road making and earth moving equipment in Estonia. The r …
  • 世界及び中国のPVC帯電防止剤市場2017
    The 'Global and Chinese PVC Antistatic Agent Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global PVC Antistatic Agent industry with a focus on the Chinese market. The report provides key statistics on the market status of the PVC Antist …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2016213 )"心筋症(Cardiomyopathy):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)" (英文:Cardiomyopathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。